Successful repair and renewal of alveolar epithelial cells (AECs) are critical in prohibiting the accumulation of myofibroblasts in pulmonary fibrogenesis. MicroRNAs (miRNAs) are multifocal regulators involved in lung injury and repair. However, the contribution of miRNAs to AEC2 renewal and apoptosis is incompletely understood. We report that miRNA-29c (miR-29c) expression is lower in AEC2s of individuals with idiopathic pulmonary fibrosis than in healthy lungs. Epithelial cells overexpressing miR-29c show higher proliferative rates and viability. miR-29c protects epithelial cells from apoptosis by targeting forkhead box O3a (Foxo3a). Both overexpression of miR-29c conventionally and AEC2s specifically lead to less fibrosis and better recovery in vivo. Furthermore, deficiency of miR-29c in AEC2s results in higher apoptosis and reduced epithelial renewal. Interestingly, a gene network including a subset of apoptotic genes was coregulated by both Toll-like receptor 4 and miR-29c. Taken together, miR-29c maintains epithelial integrity and promotes recovery from lung injury, thereby attenuating lung fibrosis in mice.
mechanical damage, innate immune, ECM, environmental exposure, and the aging process in epithelial cells, as well as epithelial interplay with other cell types, could be shaped by the regulation of microRNAs (miRNAs) (6) (7) (8) (9) . It is well known that miRNAs are a type of conserved, multifocal regulator proven to be potential therapeutic interventions.
miRNAs are 22-to 25-nucleotide-long, noncoding RNAs that mediate mRNA cleavage, translational repression or mRNA destabilization. Its biogenesis begins with Drosha, RNase III endonucleases, cleaving primary (pri)-miRNAs to pre-miRNAs in the nucleus. Subsequently, pre-miRNAs are catalyzed by another RNase III, Dicer, to from mature miRNAs in the cytoplasm (10, 11) . Aberrant miRNA expression profiles have been identified in interstitial lung diseases (12) , in the serum of individuals with IPF (13) , and in different stages of pulmonary fibrosis in bleomycintreated mouse models (14) . miRNAs have been found to regulate the activation, proliferation, differentiation, migration, apoptosis, senescence, and mesenchymal properties of myofibroblasts or fibroblasts in the lung (15) (16) (17) (18) . They target or interplay with multiple pathways, including transforming growth factor (TGF)-b and mothers against decapentaplegic homolog 3 (SMAD3) (19) , wingless-type (Wnt), and b-catenin (20) , and many more in lung fibroblasts. The investigation of miRNAs in lung epithelial biology is still in its infancy.
The miRNA-29 (miR-29) family includes miR-29a, miR-29b, and miR-29c. Among them, miR-29b2 and miR29c are on chromosome 1q32.2, and they are transcribed together. These miR-29s are regarded as important regulators in several diseases and organs (21, 22) , specifically fibrotic diseases. miR-29 family members are perceived as "master fibro-miRNA" regulators (23, 24) . It has been reported that expressions of miR-29b and -c were decreased in bleomycin-treated mouse lungs and TGF-b1-treated lung fibroblasts. miR-29 represses collagen genes and mediates ECM-associated and fibrogenesis genes in fibroblast cell lines (24, 25) . There are reports on the role of miR-29 in lung fibroblasts, showing that miR-29 can mediate TGF-b1-induced ECM synthesis through activation of the phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT) pathway, and increases apoptosis sensitivity via modulation of the cell-surface death receptor, Fas (15, 26) . An aberrant protein phosphatase 2A/histone deacetylase C4/miR-29 signal axis can regulate collagen I expression in IPF fibroblasts (27) . In regard to lung epithelial cells, miR-29 family members were found to be expressed in fetal lung AEC2s, and are thyroid transcription factor (TTF)-1-driven mediators of surfactant protein (SP)-A expression and AEC2 differentiation through repression of TGF-b signaling (28) . However, the role of miR-29 in AEC2s in the adult lung has not been explored.
To determine the role of miR-29 in lung epithelial cells, we first demonstrated that miR-29c expression was downregulated during the fibrotic phase in the mouse bleomycin model of pulmonary fibrosis and in AEC2s of individuals with IPF. We provide in vitro and in vivo proofs that miR-29c promotes the proliferation and viability of AEC2s, and inhibits the apoptosis of epithelial cells with various injuries. We further generated new mouse lines and performed gain-and loss-offunction studies to ascertain the roles of miR-29c in epithelial protection and in attenuation of lung fibrosis. Together, these data demonstrate a critical role of epithelial miR-29c in preventing fibrosis by targeting the alveolar epithelial compartment.
Materials and Methods

Mice
All animal experiments were permitted by the Institutional Animal Care and Use Committee at Duke University (Durham, NC) and Cedars-Sinai Medical Center (Los Angeles, CA) (protocols IACUC004722 and IACUC004751, respectively).
Generation of miR-29c-Overexpression-Stable Cell Line
The miR-29c overexpression mouse epithelial cell line was generated based on a previously described strategy (29, 30) .
Generation of miR-29c-Overexpression-Transgenic Mice
Lentivirus vector harboring pre-mmumiR-29c (pSico-miR-29c) was linearized and was injected to C57Bl/6J mouse embryos to generate conditional miR-29c-overexpression-transgenic (miR-29c Tg ) mice. These mice express green fluorescent protein (GFP) in all cell types, as confirmed by immunofluorescence staining shown in Figure E4 in the online supplement. Upon crossing with cre recombinase (Cre) mouse lines, miR-29c starts to overexpress.
Human Lung Samples
All experiments using human lung samples were approved by the Cedars-Sinai Medical Center Institutional Review Board and were in agreement with the instructions defined by the Board (IRB: Pro00035396). All subjects gave written informed consent.
Mouse Lung Fibrosis Model
Bleomycin instillation was described previously (2) . Under anesthesia, 2.5 U/kg bleomycin (Hospira, Lake Forest, IL) in saline was injected into the mouse trachea with a 25-guage needle inserted between the cartilaginous rings of the trachea. Control animals received saline alone. The tracheostomy site was closed by wound clip, and the animals were allowed to recover. Mouse lungs were collected at different time points for experiments.
Statistical Analysis
Data are presented as the mean (6SEM). Student's t tests (two-tailed) or Wilcoxon's rank-sum test was used for nonparametric two comparisons. One-way ANOVA with Bonferroni test or Kruskal-Wallis test was performed for multiple comparisons. Ordinary two-way ANOVA with Sidak's multiple comparisons test was conducted for grouped data sets. Log-rank tests were performed to compare the survival differences. Results were considered statistically significant at P less than or equal to 0.05. Statistical analysis was done with GraphPad Prism software (GraphPad Software Inc., La Jolla, CA).
Results
miR-29c Expression Is Detected in AEC2s and Is Lower in Fibrotic Lung Tissues
To explore the expression pattern of mature miR-29c, we performed miRNA array analysis on mouse lung tissue after bleomycin-induced injury. Expression of miR-29c-3p was decreased starting from Day 7 after injury when compared with untreated mice ( Figure 1A) . Confirmation of miR-29c-3p expression by quantitative RT-PCR revealed that its expression was down-regulated from Day 7 after injury and remained at low levels during the fibrotic phase ( Figure 1B) . The decreased expression of miR-29c-3p in fibrotic lung tissue found in our studies is consistent with others (24, 31) . To gain more insight on the expression and location of miR-29c in human lung, we detected miR-29c precursor expression by using the Basescope in situ hybridization assay (Advanced Cell Diagnostics, Inc., Newark, CA). miR-29c precursors were found in human type II (HTII)-280 1 AEC2s from explant lung tissues of healthy individuals or those with IPF. The percentage of dual pre-miR-29c 1 HTII-280
1 AEC2s within total HTII-280 1 AEC2s were significantly fewer in fibrotic areas of lung tissue from individuals with IPF ( Figures 1C and 1D ). The percentages of pre-miR-29c
1 AEC2s are similar between nonfibrotic and fibrotic region in individuals with IPF ( Figures E1A  and E1B ). The colocalization of miR-29c precursor and a-smooth muscle actin 1 were found in both non-IPF and IPF lung tissue ( Figure 1E ), which is consistent with other studies (32) . Thus, the fibrotic phenotype may be dependent on miR-29c deficiency in AEC2s.
miR-29c Promotes Epithelial Cell Proliferation
To decipher the function of miR-29c on epithelial proliferation in vitro, we first established a mouse epithelial cell line overexpressing miR-29c using the same strategy as described previously (29) . Briefly, miR-29c-overexpressing epithelial cell line was generated by transducing lentivirus harboring pre-mmu-miR-29c (pSico-miR-29c) or empty lentivirus (pSico) to mouse lung epithelial cell line (MLE12) cells. One copy of pre-mmu-miR-29c gene was inserted following the cytomegalovirus (CMV)-GFP cassette in a pSico vector (30) . The presence of Cre enables the removal of the CMV-GFP cassette and triggers the expression of miR-29c ( Figure E2A ). The confirmation of Cre-activated GFP removal was analyzed by PCR, as shown by the bands indicating the recombination and unrecombination of DNA ( Figure E2B ). Elevated levels of miR29c were confirmed in cells overexpressing miR-29c (Figure 2A) . To test the assumption that the gain of miR-29c function would increase epithelial proliferation and viability, we performed the proliferation and viability assays. As 
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Pre-hsa-mir-29c Representative of three independent experiments (n = 5). *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, by Student's t test (A) or two-way ANOVA (B and C). Data presented are means (6SEM). PI, propidium iodide. compared with mouse lung epithelial control cells (Mlesico), mouse lung epithelial pre-mmu-miR29c over-expressing cells (Mle29c) demonstrated significantly enhanced cellular growth ( Figure 2B ) and higher cellular viability ( Figure 2C ). These in vitro data demonstrate that miR-29c promotes the growth and survival of lung epithelial cells.
miR-29c Inhibits Bleomycin-induced Epithelial Apoptosis
We further investigated the apoptotic response of miR-29c overexpression in epithelial cells to bleomycin treatment in vitro. Treatment with bleomycin induced a higher proportion of apoptotic cells (annexin V
1
) and necrotic cells (propidium iodide [PI] 1 ). However, these effects were dampened by miR-29c overexpression ( Figure 2D , Figures E3A and E3B ). Cellular Inhibitor of apoptosis 1 (cIAP1) can inhibit apoptosis and regulates caspases. Expression of cIAP1 was decreased after bleomycin treatment, and we found that miR-29c overexpression in Mle29c cells led to restoration of cIAP1. Cleaved-caspase (c-casp)-3 plays a central role in activating a cascade of caspases in the execution of apoptosis. Notably, bleomycin significantly induced the c-casp-3 expression, and miR-29c overexpression dampened the induction of c-casp-3 levels by bleomycin ( Figure 2F, Figures E3C and E3D ). These data indicate that miR-29c functions to dampen the damage-induced epithelial apoptosis.
miR-29c Inhibits Endoplasmic Reticulum Stress-induced Epithelial Apoptosis
We further evaluated how miR-29c functions in endoplasmic reticulum (ER) stress-induced apoptosis in lung epithelial cells. Tunicamycin is an antibiotic derived from Streptomyces lysosuperificus, and contains glucosamine. It can impair the glycosylation during protein synthesis and interrupt protein folding in the ER or inhibit the secretion of some proteins from the cell, thus inducing ER stress. Tunicamycin-stimulated ER stress can trigger cell apoptosis both in vivo and in vitro (33, 34) . To investigate the role of miR-29c in ER stress-induced cell apoptosis and death, we examined survival of Mlesico or Mle29c epithelial cells against tunicamycin. Epithelial cells overexpressing miR-29c showed significant resistance to ER stress-induced cell apoptosis compared with control cells, as determined by flow cytometry analysis of annexin V expression ( Figure 2E, Figure E3E ). There was a slight decrease in the percentage of necrotic cells in Mle29c cells over Mlesico cells ( Figure  E3F ). These data demonstrate that miR-29c protects against ER stress-induced epithelial cell apoptosis.
Conventional Overexpression of miR-29c Reduces Pulmonary Fibrosis
We further sought to determine whether miR-29c could protect mice from bleomycin-induced pulmonary fibrosis in vivo. Conditional miR-29c overexpression mice, termed miR-29c
Tg , were generated in the laboratory, as confirmed by immunofluorescence analysis of GFP expression ( Figure E4 ). To conventionally overexpress miR-29c, we crossed miR-29c
Tg mice with CMV-Cre mice. We confirmed that miR-29c was overexpressed in the lungs of CMV-Cre; miR-29c
Tg mice when compared with the lungs of littermate control mice ( Figure 3A) . Notably, miR-29c mice showed a marked increase in mortality after bleomycin-induced lung injury as compared with littermate control mice ( Figure 3B ), and they showed a decreased fibrotic response to the same doses of bleomycin, as indicated by lower hydroxyproline content in lung tissues 21 days after bleomycin exposure ( Figure 3C ). Less severe fibrosis (56%) in miR-29c Tg mice was also illustrated by less distorted lung structure and less collagen staining ( Figures 3D and 3E) . The diminished fibrotic response in conventional miR-29c-overexpressing mice led us to further investigate the cell-specific effect of miR-29c in AEC2s.
Specific Overexpression of miR-29c in AEC2s Reduces Pulmonary Fibrosis
To determine whether overexpression of miR-29c in AEC2s affects the outcome of bleomycin-induced pulmonary fibrosis, we crossed miR-29c
Tg with Sftpc-Cre mice to generate Sftpc-Cre;miR-29c
Tg mice. The mature miR-29c expression in lung tissue of uninjured Sftpc-Cre;miR-29c
Tg mice was higher than those in the lungs of their littermates ( Figure 4A ). We hypothesized that higher miR-29c in AEC2s would lead to diminished susceptibility to bleomycin injury. Indeed, Sftpc-Cre;miR-29c
Tg mice showed 31% less lung fibrosis at Day 21 after bleomycin treatment as compared with injured littermate controls, although Sftpc-Cre;miR-29c Tg mice only showed marginally better survival ( Figures 4B  and 4C ). Sftpc-Cre;miR-29c
Tg mice demonstrated a less fibrodestructive response and less accumulated abundance of collagen (Figures 4D and 4E ).
miR-29c Prohibits Apoptosis of AEC2s by Targeting Foxo3a
Successful recovery from lung injury requires the repair and renewal of AECs (4). We analyzed the role of miR-29c in the epithelial repair and renewal process. We employed an approach specifically designed to dissociate and fractionate lung tissue to produce and enrich AEC2 fraction, as indicated previously here. The AEC2 fraction was isolated as CD24 
Sca1
2 subset (4, 35). The higher percentage of CD24 
2 AEC2s in Sftpc-Cre;miR29c Tg mice was observed at Day 14 after bleomycin injury (Figures 5A and 5B) . Furthermore, we observed significantly lower levels of apoptotic CD24 2 Sca1
2
AEC2s in bleomycin-injured lungs from Sftpc-Cre;miR-29c Tg mice versus WT mice ( Figures 5C and 5D ).
Forkhead box o (Foxo3a) is a transcription factor that belongs to the O subclass of the forkhead family. It functions as a trigger for apoptosis through upregulation of genes necessary for cell death and down-regulation of antiapoptotic proteins (36) . TargetScan predicts that Foxo3a is a potential target for miR-29c-3p ( Figure 5E ). We compared AEC2s isolated from Sftpc-Cre;miR-29c
Tg and littermate control mice without bleomycin challenge. The AEC2s from Sftpc-Cre;miR-29c
Tg demonstrated decreased Foxo3a protein levels (Figures 5F and 5G). Foxo3a overexpression reduced the cell proliferation in both Mlesico and Mle29c epithelial cells ( Figures  E5A-E5C ). The overexpression of Foxo3a also resulted in an increase in apoptosis upon bleomycin treatment in vitro ( Figure E5D and E5E) . Thus, Foxo3a overexpression is contrary to miR-29c overexpression phenotype in vitro in AEC2 cell line. The Foxo3a targeting effect by miR-29c is consistent with the previous report in human lung myofibroblast cells (32) . Taken together, our gain-of-function transgenic mouse strategy supported an underlying role for miR-29c in the maintenance of AEC2s.
Loss of miR-29c Increases AEC2 Apoptosis and Retards AEC2 Renewal
To ascertain the role of miR-29c in AEC2 function, we sought to determine whether loss of miR-29c could affect the regenerative ability of lung AEC2s. By adopting miR29b2/c f/f mice and crossing them with Sftpc-Cre mice, we generated mouse lung epithelial-specific miR-29b2/c knockout mice (Sftpc-Cre;miR-29b2/c f/f ). miR-29b2/c knockout was associated with a higher percentage of different stages of apoptotic CD24 
Sca-1
2 AEC2s within the lung epithelial cell fraction by FACS analysis ( Figure 6A ) and an increased percentage of c-casp-3 1 cells within Sftpc 1 AEC2s (Figures E6A and E6B ). There were also larger numbers of CD24 
2 AEC2s at different stages of apoptosis from dissociated lung tissue of miR-29b2/c knockout mice ( Figure 6B ). To evaluate the role of miR-29c in AEC2 organoid growth, flow-sorted CD24 2 Sca-1 2 AEC2s were cocultured with mouse lung fibroblasts (MLg2908) embedded in matrigel medium mix for the generation of clonally derived three-dimensional organoids ( Figure 6C ). AEC2s isolated from Sftpc-Cre;miR-29b2/c f/f mice failed to augment in terms of organoid number ( Figure 6D ), and yielded substantially smaller organoids ( Figure 6E ). Collectively, these loss-of-function experiments suggested a protective role of miR-29c in the apoptosis and renewal of AEC2s. Tg (n = 8) and littermate control (n = 8) mice harvested on Day 21 after bleomycin treatment (2.5 U/kg). Scale bars: 100 mm. *P < 0.05, ****P , 0.0001 by Student's t test (A), log-rank test (B), or one-way ANOVA (C). (D and E) Scale bars: 1 mm, 100 mm (insets). Data presented are means (6SEM).
critical for epithelial renewal and inhibition of apoptosis (4, 37) . We therefore investigated the converging and independent genes modulated by miR-29c and TLR4. We assembled all genes that showed regulation either by miR-29c or TLR4 and analyzed for similarity (fold change of .1.5). We generated four easily distinguishable compartments of genes, elevated or decreased either by miR-29c or by TLR4 ( Figure 7A ). We used network analysis to determine whether miR-29c and TLR4 coordinately regulated genes interacted. The interactions among miR-29c-and TLR4-modulated genes indicate that several genes may coordinately function together. In addition, 8 out of 12 genes within the network are associated with apoptosis ( Figure 7B ). This regulation included both the elevated and decreased genes.
Discussion
We have explored the role of miR-29c in regulating AEC2 renewal and apoptosis after noninfectious injury-induced lung fibrosis. Our newly acquired Basescope premiRNA technology detected a previously unrecognized expression pattern of pre-miR-29c in human healthy and IPF type II cells. Overexpression of miR-29c increased epithelial cell proliferation and viability, and protected bleomycin and ER stress-induced epithelial apoptosis. In vivo studies further confirmed that AEC2 miR29c-overexpressing mice showed a decrease in fibrosis upon injury, and these mice demonstrated enhanced restoration of AEC2s and inhibited epithelial apoptosis that is regulated by Foxo3a, a miR-29c target. In addition, loss of miR-29c in AEC2s revealed an elevated apoptotic response and mitigated a regenerative phenotype. Finally, miR-29c is associated with innate immune receptor TLR4 interaction network in modulating AEC2 apoptosis. Most of the previous miR-29 studies performed in lung tissue were focused on mesenchymal cell types, especially fibroblasts (25) (26) (27) 32) . Fibroblasts show reduced expression of miR-29 when growing on ECM derived from decellularized IPF lung, and miR-29 can target ECM proteins associated with IPF, suggesting that miR-29 is engaged in the vicious signaling circle orchestrated by the IPF ECM and fibroblasts (25) . In this setting, polymerized type I collagen, an ECM component, interacted with IPF fibroblasts. This resulted in an abnormal protein phosphatase 2 (PP2A) function, leading to histone deacetylase 4 (HDAC4) phosphorylation and reduced nuclear translocation of HDAC4. This axis suppresses miR-29, activating the positive feedback loop, thus inducing an increase in type I collagen expression (27) . In addition, miR-29 can be reduced by TGF-b1. miR-29 is also involved in prosurvival phosphoinositide 3-kinase (PI3K)-protein kinase B (Akt) signaling pathway by TGF-b1 in lung fibroblast cell lines (26) .
Furthermore, miR-29 expression is also detected in another mesenchymal cell type, smooth muscle cells, as it is colocalized with a-smooth muscle actin 1 cells of blood vessel walls in Embryonic Day 18.5 mouse lung and of distal pulmonary artery in human lung (32) . These identified cell types are consistent with studies done in abdominal aortic aneurysms (38) , systemic sclerosis (39) , and cardiac fibrosis (40) . Aside from that, the role of miR-29 in other cell types has been explored (41) (42) (43) . For example, miR-29 expression can be detected in Tg (n = 3) and littermate control (n = 3) mice without challenge. GAPDH bands were from the same gels used to detect the corresponding Foxo3a bands. (G) Foxo3a/GAPDH densitometry ratios were calculated. Representative of three independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001, by Student's t test (D and G) or two-way ANOVA (B). Data presented are means (6SEM). FSC, forward scatter. mouse and human fetal lung AEC2s (28) . The miR-29 family was found to be upregulated in AEC2s from human fetal lung during cAMP-induced differentiation and significantly increased in adult mouse lungs compared with neonatal mouse lungs (44) . Whether miR-29 is expressed in the epithelial cells of human adult lung was not yet discovered, and the role of miR-29 in epithelial cells was unknown. In our current study, we discovered that miR-29c was expressed on AEC2s in healthy and IPF human lungs. We further demonstrated that miR-29c functions as a promoter of epithelial cell renewal and inhibitor for epithelial apoptosis by gain-and loss-offunction studies in vitro and in vivo.
Of note, the abnormal ECM in fibrotic lung can alter the behavior of epithelial and mesenchymal cells, and drive progressive fibrogenesis without any further initiating trigger. Although the feedback loop of IPF ECM and miR-29 have been examined in fibroblasts (25) , the contribution of ECM signaling and miRNA to the modulation of homeostasis and renewal in epithelial cells has not been well studied until now. It is plausible that, during fibrogenesis, increased ECM reduces miR-29 in lung epithelial cells. Alternatively, perturbation of the stiff environment in the fibrotic lung could diminish miR-29, thereby activating apoptosis of pulmonary epithelial cells. In addition, the regulation of miR-29c-mediated epithelial cell renewal or apoptosis by different components of the ECM, such as collagen and hyaluronic acid, needs to be investigated in the future.
Lung epithelial cell renewal and repair is essential for host survival and subsequent fibrogenesis in lung injury. Timely repair of AEC2s is critical for restoration of lung function and quality of life. Inappropriate repair can result in disrupted barrier function and promote fibrogenesis, thus leading to potentially life-threatening outcomes. miRNAs can suppress protein expression by cleavage of mRNA or translational suppression. miRNAs are major players in regulating various biological processes ranging from development to homeostasis and disease. Recent studies have identified several miRNAs that play a major role in lung epithelial injury and repair. Loss of miR34a in aged mice is beneficial in experimental lung fibrosis, and miR34a can induce AEC2s from Sftpc-Cre;miR-29b2/c f/f (n = 175) and littermate control mice (n = 156). Representative of three independent experiments were performed; n = 3 in each group. ***P < 0.001, ****P < 0.0001, by Student's t test (D and E) or two-way ANOVA (B). Scale bar: 1 mm. Data presented are means (6SEM). cellular senescence, apoptosis, and mitochondrial aberrations in AECs (18) . Indeed, expression levels of miR34 family members were higher in AEC2s from individuals with IPF, and their expression was associated with AEC2 senescence (45) . miR-130b-3p was down-regulated in IPF lungs, and it can inhibit the epitheliuminduced collagen 1 expression and enhance proliferation and migration ability of fibroblasts in coculture systems through insulin like growth factor 1 (IGF-1) (46) . Furthermore, miR-323a-3p is downregulated in the epithelial cells of lungs with bronchiolitis obliterans syndrome after lung transplantation, IPF, and experimental fibrotic models. It can also modulate fibrotic pathways by directly targeting TGF-a and Smad2 in TGF-b signaling and lower casp-3 expression in the epithelium. Induction of epithelial miR323a-3p can inhibit fibroblast activation, thus revealing a protective role of this miRNA (47) . Our current data showed a protective effect of miR-29c, which is essential in AEC2 renewal and apoptosis. We found that mice with miR-29c overexpression showed increased survival and decreased fibrosis. Indeed, AEC2-specific miR-29c overexpression has a similar protective effect by targeting the expression of apoptosis trigger, Foxo3a. In addition, AEC2s lacking miR-29c exhibit elevated apoptosis and deficiency of renewal. These data are, to our knowledge, the first to suggest a role for miR-29c in maintaining AEC2 function in the context of tissue fibrosis.
We defined an apoptosis associated gene network coordinately regulated by miR-29c and TLR4 that is specific for lung epithelial cells. This gene network includes Aldh1a1, Celsr1, Daam2, Fank1, Large, Ndrg1, Naalad2, Ogn, Timp1, Trps1, Vcam1, and Zfp629. Within the 12 genes, 8 genes (Trps1, Aldh1a1, Vcam1, Timp1, Fank1, Ogn, Naalad2, and Ndrg1) are previously reported to be correlated with apoptosis. Tlr4 is directly associated with Aldh1a1, Vcam1, Timp1, and Fank1, whereas miR29c is directly associated with Daam2, Large, and Ndrg2. This network includes genes both positively and negatively coexpressed, which implicate an miR-29c-and TLR4-regulated apoptosis response as a comprehensive regulatory module.
It is intriguing how miR-29 is regulated. miRNA can be regulated both transcriptionally (changes in gene expression and promoter hypermethylation) and posttranscriptionally (changes in miRNA processing), as well as by endogenous (hormones, cytokines) and exogenous (xenobiotics) compounds. miR-29 is negatively regulated by TGF-b-Smad3 signaling via inhibiting myogenic differentiation 1 (MyoD) binding and enhancing Yin and Yang 1 (YY1)-recruited Polycomb association in a muscle cell line (48) . In addition, miR-29 exists in a feedback loop involving NF-kB and YY1. miR-29 is repressed by NF-kB and acts through YY1 and the Polycomb in myoblasts. During myogenesis, miR-29 is triggered to promote myogenesis by abrogating the regulatory circuit on YY1 (49) . It has been shown that activation of NF-kB activated by hyaluronan and TLR2/4 in epithelial cells can induce apoptosis (37) . This implies that there might be connections between hyaluronan, TLR2/4, NF-kB, and miR-29c. It will be very interesting to explore the role of miR-29c within the signaling cascade under hyraluronan-and TLR2/4-induced NF-kB activation in epithelial cells. Although this exceeds the range of this study, the dedicated process of miR-29 upstream regulation should be emphasized in future investigations.
miRNA has been reported to block pulmonary fibrosis in experimental models (31) . It has previously been reported that intravenous injection of synthetic RNA duplexes can increase miR-29 levels in vivo for several days. Moreover, therapeutic delivery of miR-29 mimics during bleomycin-induced pulmonary fibrosis restored endogenous miR-29 function, decreased collagen expression, and blocked and reversed pulmonary fibrosis (50). It is conceivable that the intravenously injected miR-29 functions on multiple cell types. Our current study focused on the function of miR-29c in the epithelial cell compartment, and supports a previously unrecognized role for miR29c in limiting the extent of the fibrosis by inhibiting AEC2 apoptosis and, potentially, by promoting AEC2 renewal.
Taken together, our results indicate that miR-29c suppresses AEC2 apoptosis and perpetuates lung epithelial renewal by potentially targeting Foxo3a, thus limiting the extent of tissue fibrosis. These studies provide new insights into the antifibrotic roles of miR-29c through its impact on AEC2s, and further support a role for this unique regulatory pathway in lung disease. n Author disclosures are available with the text of this article at www.atsjournals.org.
